AMTP Welcomes CHIPS Act Funding; Says More Needs to Be Done
The following statement from Brewer Science Executive Vice President and AMTP Executive Director Dan Brewer in response to the final adoption of CHIPS Act funding signed earlier today by President Biden to help boost the U.S.-based semiconductor supply chain.
ROLLA, Mo, Aug. 9, 2022 /PRNewswire/ -- "AMTP welcomes bipartisan adoption of CHIPS Act funding and its related provisions to secure and bolster domestic semiconductor production here in the United States. It is important to note, however, that more needs to be done to ensure our economic and national security, which is increasingly dependent upon such essential microelectronic components.
"In addition to spurring the domestic manufacture of these critical components, we believe Congress must also find additional ways to recognize and support the materials and supply chains necessary for any such expanded manufacturing capacity.
"Congress and the Biden Administration also need to re-examine the pending expiration of federal tax provisions designed to support science and technology research and development. At a time when our microelectronic supply chains and essential components are at risk, it would be an overall step backward to allow such incentives to lapse."
Elbit Systems Ltd. ("Elbit Systems" or the "Company") announced today that it was awarded an initial contract of approximately $37 million to supply Iron Fist Active Protection Systems (APS) to General Dynamics Ordnance and Tactical Systems...
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...
U.S.-based tech startup Iozera, in collaboration with the Government of Morocco, announces an initiative set to transform the AI industry. Iozera has announced the signing of a Memorandum of Understanding (MOU) for the establishment of a pioneering...
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...
With a remarkable achievement of 81.556 billion yuan in operating revenue, marking an 11.74% increase from the previous year, and a net profit attributable to shareholders of 7.039 billion yuan, soaring by 27.21%, JA Solar hit historic highs in both...